According to a resolution by the 2016 Annual General Meeting the Nomination Committee shall consist of the Chairman of the Board and one representative for each of the four largest shareholders in terms of voting power at the end of October 2016.

The Nomination Committee is responsible for submitting nominations to the Annual General Meeting for Chairman of the Board and other Board members, and for proposing director’s fees for each of the Board members, the chairman of the Annual General Meeting and, where appropriate, auditors and auditors’ fees.

The largest shareholders as of October 31, 2016 were Abanico Invest AB (Mats Andersson), Protenus Ltd (Gudmundur Palmason), Gadice ehf. (Agusta Gudmundsdottir) and Fibonacci Asset Management (Björn Algkvist), who thereby constitute the nomination committee for the Annual General Meeting 2017. In the Nomination Committee Abanico Invest AB is represented by Håkan Roos.

Shareholders wishing to submit proposals to the Nomination Committee prior to the AGM may send an e-mail to IR@enzymatica.com or use the following address:

Enzymatica AB
Att: Nomination Committee
Ideon Science Park
223 70 Lund
Sweden

This content needs to be approved before viewing.
Yes, I accept
No, I decline